Experience

• • Presidio, a Clayton, Dubilier & Rice portfolio company, in its acquisition of a majority stake in Contender Solutions, an Elite ServiceNow partner.
  • Konica Minolta, a Japanese multinational equipment and materials manufacturer operating in the healthcare and industrial industries, in the $600 million sale of its subsidiary, Ambry Genetics, to Tempus AI.
  • The Standard in its acquisition of The Allstate Corporation’s Employer Voluntary Benefits business in a transaction valued at approximately $2 billion.
  • Clayton, Dubilier & Rice in its acquisition, together with TowerBrook, of R1 RCM, a provider of technology-driven solutions that impact the patient experience and financial performance of healthcare providers, at an enterprise value of $8.9 billion.
  • Hamilton Lane in the acquisition of a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors through funds managed by Hamilton Lane.
  • Valenz Health, a Kelso & Company portfolio company and platform of integrated cost containment and payment integrity solutions, in its acquisition of Healthcare Bluebook, a healthcare cost and quality navigation platform.
  • Clayton, Dubilier & Rice in its strategic partnership with Elevance Health, which will bring together certain care delivery and enablement assets of Elevance’s Carelon Health and CD&R portfolio companies, apree health and Millennium Physician Group.
  • The George Robert Rawlings Trust in the sale of the Rawlings Companies to New Mountain Capital Group L.P.
  • Konica Minolta, a Japanese multinational equipment and materials manufacturer operating in the healthcare and industrial industries, in the sale of its subsidiary Invicro to Calyx, a portfolio company of CapVest and leading technology-enabled provider.
  • Clayton, Dubilier & Rice in the financing aspects of its acquisition of Shearer’s Foods, a leading contract manufacturer and private label supplier in the snack industry in North America.
  • Sawai and Sumitomo in the $210 million sale of its subsidiary Upsher-Smith Laboratories to Bora Pharmaceuticals.
  • Kelso & Company in its investment in Valenz.
  • StanCorp Financial Group in its acquisition of the Life & Disability business from Elevance Health.
  • Gentiva, a Clayton, Dubilier & Rice portfolio company and leading hospice, palliative, and personal care company, in its acquisition of Heartland hospice and home care.
  • Clayton, Dubilier & Rice in its acquisition of a majority stake in the industrial businesses of Roper Technologies, which operates market-leading businesses that design and develop vertical software and application-specific products, in a transaction valued at $3.7 billion.
  • Clayton, Dubilier & Rice in its acquisition of a 60% interest in Humana’s Kindred at Home Hospice and Personal Care divisions, valued at $3.4 billion.
  • Resonetics, a leader in micro-manufacturing for the medical device and diagnostics equipment, in its acquisition of EaglePicher Medical Power, a medical device manufacturer.
  • Blackstone as lead investor in DNAnexus’ $200 million financing round.
  • LIBERTY Dental Plan Corporation, a dental benefits administrator, in its sale of a majority stake in LIBERTY to Welsh, Carson, Anderson & Stowe, a private equity firm.
  • Carlyle in its strategic partnership with Orsini, an independent specialty pharmacy focused on rare diseases, gene therapies and complex conditions.
  • Carestream Dental, a Clayton, Dubilier & Rice portfolio company and leading provider of dental technology, in the $600 million carve-out sale of its Scanning Technology business to Envista, a leading global dental products company.
  • Kindred Healthcare, a TPG portfolio company and leading specialty hospital company delivering acute health services, in its sale to LifePoint Health, a leader in the delivery of community-based care.
  • Carlyle in its investment in Resonetics, a leader in micro-manufacturing for the medical device and diagnostics equipment industries, valuing the company at approximately $2.25 billion.
  • HealthEdge and its controlling shareholder, Blackstone, in the acquisition of Wellframe, a digital health management company.
  • Carlyle in its acquisition of a majority stake in Saama, a leading AI-driven intelligent clinical cloud company that enables the life sciences industry to conduct faster and safer clinical developments and regulatory programs.
  • Sun Life in its $2.475 billion acquisition of DentaQuest.
  • agilon health and Clayton, Dubilier & Rice in the $587 million secondary offering of agilon health common stock.
  • Blackstone in its investment in Medable, the leading cloud platform for patient-centered clinical research, valuing Medable at $2.1 billion.
  • Blackstone as a lead investor in the formation of Hydrogen Health.
  • agilon health in its $1.2 billion initial public offering.
  • Clayton, Dubilier & Rice in its acquisition of Millennium Physician Group, one of the largest independent primary care practices in the country.
  • CPP Investments as lead investor in a $400 million Series C financing for insitro, a machine learning-driven drug discovery and development company.
  • Blackstone in its investment in Ginger, a leader in on-demand behavioral healthcare.
  • Carlyle in its $2.6 billion sale of MedRisk to CVC Capital Partners.
  • HCA Healthcare in its acquisition of a majority stake in Brookdale Health Care Services, the home health, hospice and outpatient therapy business of Brookdale Senior Living.
  • J.P. Morgan Securities, as financial advisor to AmerisourceBergen, in AmerisourceBergen’s acquisition of Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion in cash and stock.
  • HealthEdge and its controlling shareholder, Blackstone, in the acquisition of Altruista, a care management software company that delivers care management and population health management solutions that support value-based and person-centered care models.
  • StepStone Group as lead investor in the $670 million closing of Ampersand Continuation Fund, together with related investment vehicles, formed to acquire the equity interests of three portfolio companies previously held by multiple mature Ampersand funds.
  • Blackstone in its investment in Bright Health as part of a $500 million Series E financing round.
  • HealthEdge and its controlling shareholder, Blackstone, in the acquisition of The Burgess Group, an innovative payment integrity software company focused on improving healthcare payment operations through a cloud-based technology platform, particularly with respect to health regulatory and data privacy and security compliance.
  • Precision Medical Group in its $2.4 billion sale to Blackstone.
  • Leading private equity firms in physician practice management transactions and provider entity investments.
  • Fortune 500 companies and other large, multi-lateral organizations on managed care market entry, scale-up, regulatory compliance, and strategic growth initiatives.
  • Numerous provider entities, healthcare technology companies, and service vendors in addressing complex HIPAA compliance issues.